Your browser doesn't support javascript.
loading
Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.
Patil, S; Figlin, R A; Hutson, T E; Michaelson, M D; Negrier, S; Kim, S T; Huang, X; Motzer, R J.
Affiliation
  • Patil S; Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. patils@mskcc.org
Br J Cancer ; 106(10): 1587-90, 2012 May 08.
Article in En | MEDLINE | ID: mdl-22568998
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Interferon-alpha / Angiogenesis Inhibitors / Indoles / Kidney Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Interferon-alpha / Angiogenesis Inhibitors / Indoles / Kidney Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido